Hinge Health Inc

Robinson Elliott’s February 17 sale of Hinge Health shares is a low‑impact liquidity move—no major ownership shift, just routine portfolio rebalancing amid a rally.

Hinge Health CEO’s 2026 insider trade shows strategic liquidity and voting‑class consolidation, reflecting confidence in post‑earnings growth.

CEO Daniel Perez’s disciplined 166k‑share purchase signals strong confidence in Hinge Health’s upside after a Q4 earnings beat and 2026 revenue growth.